Skip to main content
. 2022 Mar 18;63(4):349–356. doi: 10.3349/ymj.2022.63.4.349

Table 2. Risk Factors for Procedure-Related Complications in Patients with Large and Giant Aneurysms Treated by FRED.

Variables No. of patients Procedure-related complications (%) p, Univariate p, Regression (OR, 95% CI)
Yes (n=6) No (n=27)
Age (yr) 56.5±16.0 58.3±14.6 0.768*
Sex 0.208
Male 10 3 (30.0) 7 (70.0)
Female 23 3 (13.0) 20 (87.0)
Hypertension 0.467
Yes 12 2 (16.7) 10 (83.3)
No 21 4 (19.0) 17 (81.0)
Diabetes 0.625
Yes 5 1 (20.0) 4 (80.0)
No 28 5 (17.9) 23 (82.1)
Smoking 0.094 0.169 (1.682, 0.874–5.984)
Yes 4 0 (0) 4 (100)
No 29 6 (20.7) 23 (79.3)
Dyslipidemia 0.108
Yes 3 0 (0) 3 (100)
No 30 6 (20.0) 24 (80.0)
Location of aneurysm 0.018 0.034 (6.532, 1.335–17.816)
ICA 22 2 (9.1) 20 (90.9)
Non-ICA 11 4 (36.4) 7 (63.6)
Type of aneurysm 0.352
Saccular 24 4 (16.7) 20 (83.3)
Non-saccular 9 2 (22.2) 7 (77.8)
Aspirin reaction units 494.3±47.2 462.5±44.9 0.354*
P2Y12 reaction units 146.2±39.5 176.4±50.2 0.286*
Maximum diameter (mm) 19.0±8.3 19.7±4.6 0.889*
Neck size (mm) 12.4±6.8 9.7±4.4 0.216*
Adjunctive procedure 0.086 0.207 (0.885, 0.429–2.723)
Yes 5 0 (0) 5 (100)
No 28 6 (21.4) 22 (78.6)
Intraaneurysmal thrombus 0.296
Yes 10 1 (10.0) 9 (90.0)
No 23 5 (21.7) 18 (78.3)

CI, confidence interval; ICA, internal carotid artery; OR, odds ratio; SD, standard deviation; FRED, Flow Re-direction Endoluminal Device.

Data are presented as mean±standard deviation or n (%).

*Mann-Whitney U test.